Request Demo
Recent blog posts
Latest Hotspot
8 min read
ChiCTR2600125501 Ticagrelor Cerebrovascular Disorders Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
ChiCTR2600125501 clinical trial report covering Ticagrelor, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07564726 Amlodipine Besylate Primary hypercholesterolemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07564726 clinical trial report covering Amlodipine Besylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07593924 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Sinovac Life Sciences) Pneumococcal Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07593924 clinical trial report covering 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Sinovac Life Sciences), Phase 3, endpoints, sponsor, geo
Latest Hotspot
8 min read
NCT07563634 Brivaracetam Epilepsies, Partial Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07563634 clinical trial report covering Brivaracetam, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
SEMA7A Biologics Sequence Review Report 2026: Semaphorin-7A Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of SEMA7A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
SEMA6B Biologics Sequence Review Report 2026: Semaphorin-6B Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of SEMA6B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
ADAM5 Biologics Sequence Review Report 2026: Putative disintegrin and metalloproteinase domain-containing protein 5 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of ADAM5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
10 min read
Spontaneous bacterial peritonitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Spontaneous bacterial peritonitis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Refractory ascites Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
Explore the 2026 Refractory ascites indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Minimal hepatic encephalopathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Minimal hepatic encephalopathy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Crigler-Najjar syndrome type 2 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Crigler-Najjar syndrome type 2 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Progressive familial intrahepatic cholestasis type 5 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
7 August 2026
2026 Progressive familial intrahepatic cholestasis type 5 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built.